Contravisory Investment Management’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-8,371
Closed -$229K 417
2024
Q3
$229K Buy
+8,371
New +$229K 0.05% 205
2015
Q1
Sell
-175
Closed -$6K 177
2014
Q4
$6K Hold
175
﹤0.01% 146
2014
Q3
$7K Hold
175
﹤0.01% 122
2014
Q2
$7K Buy
+175
New +$7K ﹤0.01% 122